Business Description
Scandinavian Real Heart AB
ISIN : SE0023286836
Total Employee Number:
15Compare
Compare
Traded in other countries / regions
HEART.Sweden7820.Germany IPO Date
2021-05-10Description
Scandinavian Real Heart AB is engaged in developing an artificial heart that mimics the shape, function, and bloodflow pattern of the human heart. The company conducts research and development in medical technology and is developing an artificial heart that mimics the function of a natural heart - a so-called total artificial heart (TAH), Realhear, TAH. It is a Swedish-patented product that saves lives and improves the quality of life.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.72 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 27.8 | |||||
3-Year EPS without NRI Growth Rate | 45.4 | |||||
3-Year FCF Growth Rate | 40.6 | |||||
3-Year Book Growth Rate | -54.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.4 | |||||
9-Day RSI | 36.05 | |||||
14-Day RSI | 41.28 | |||||
3-1 Month Momentum % | 61.25 | |||||
6-1 Month Momentum % | 57.32 | |||||
12-1 Month Momentum % | 76.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.5 | |||||
Quick Ratio | 2.5 | |||||
Cash Ratio | 2.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -88.9 | |||||
Shareholder Yield % | -17.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -52.15 | |||||
ROA % | -43.66 | |||||
ROIC % | -56.24 | |||||
3-Year ROIIC % | 4.6 | |||||
ROC (Joel Greenblatt) % | -4510.79 | |||||
ROCE % | -49.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 10.44 | |||||
EV-to-EBIT | -4.46 | |||||
EV-to-EBITDA | -10.66 | |||||
EV-to-FCF | -3.57 | |||||
| Price-to-Net-Current-Asset-Value | 11.93 | |||||
| Price-to-Net-Cash | 15.18 | |||||
Earnings Yield (Greenblatt) % | -22.37 | |||||
FCF Yield % | -25.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scandinavian Real Heart AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.692 | ||
| Beta | 1.6441 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 83.17 | ||
| 14-Day RSI | 41.28 | ||
| 14-Day ATR (€) | 0.069546 | ||
| 20-Day SMA (€) | 1.81675 | ||
| 12-1 Month Momentum % | 76.71 | ||
| 52-Week Range (€) | 1.035 - 2.54 | ||
| Shares Outstanding (Mil) | 8.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scandinavian Real Heart AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scandinavian Real Heart AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 120 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 43 days | ||
| First quarter earnings results for 2026 | 2026-07-17 | In 1 day | ||
| General meeting for 2026 | 2026-05-28 17:00 | 1.53 (+0.33%) | ||
| Annual report for 2025 | 2026-05-20 | 1.50 (-1.32%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-19 | 1.23 (+0.41%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 2.34 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-28 | 1.45 (+3.96%) | ||
| General meeting for 2025 | 2025-06-12 15:00 | 1.10 (-0.90%) | ||
| Annual report for 2024 | 2025-05-23 | 1.26 (-0.40%) |
Show
Entries
Scandinavian Real Heart AB Frequently Asked Questions
What is Scandinavian Real Heart AB(FRA:7820)'s stock price today?
The current price of FRA:7820 is €1.67. The 52 week high of FRA:7820 is €2.54 and 52 week low is €1.03.
When is next earnings date of Scandinavian Real Heart AB(FRA:7820)?
The next earnings date of Scandinavian Real Heart AB(FRA:7820) is 2026-07-17 Est..
Does Scandinavian Real Heart AB(FRA:7820) pay dividends? If so, how much?
Scandinavian Real Heart AB(FRA:7820) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Scandinavian Real Heart AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers